Company profile EXAS
Exact Sciences Corp.
exact sciences is a molecular diagnostics company focused on colorectal cancer. the company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. stool-based dna (sdna) technology is included in the colorectal cancer screening guidelines of the american cancer society and the u.s. multi-society ta...sk force on colorectal cancer. for more information on exact sciences' noninvasive colon cancer screening test, visit cologuardtest.com
Show More
After 39 days of this quarter the interest is at 101.0. Based on that we can calculate that during remaining 52 days it will total up to 236.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 71 | 201 183.1% QoQ | 200 -0.5% QoQ | 115 -42.5% QoQ |
| 2020 | 201 183.1% YoY 74.8% QoQ | 122 -39.3% YoY -39.3% QoQ | 205 2.5% YoY 68.0% QoQ | 203 76.5% YoY -1.0% QoQ |
| 2021 | 185 -8.0% YoY -8.9% QoQ | 115 -5.7% YoY -37.8% QoQ | 265 29.3% YoY 130.4% QoQ | 291 43.3% YoY 9.8% QoQ |
| 2022 | 258 39.5% YoY -11.3% QoQ | 113 -1.7% YoY -56.2% QoQ | 266 0.4% YoY 135.4% QoQ | 99 -66.0% YoY -62.8% QoQ |
| 2023 | 379 46.9% YoY 282.8% QoQ | 438 287.6% YoY 15.6% QoQ | 279 4.9% YoY -36.3% QoQ | 318 221.2% YoY 14.0% QoQ |
| 2024 | 101 -73.4% YoY -68.2% QoQ | - | - | - |
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
The average 5 years interest of exact sciences login was 16.95 per week. The last year interest of exact sciences login compared to the last 5 years has changed by 58.94%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 105.18%.
Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for EXAS
Company name: Exact Sciences Corp.
Sector: Health Care and Social Assistance
Company's websiteHyperchartsYahoo FinanceMarketWatchStockTwitsSEC FilingsSwaggyStocksLatest articles
2026-03-24T09:59:35Z
Analyst Upgrades
BTIG Suspends Neutral Rating on Exact Sciences2026-03-17T20:31:00Z
BusinessWire
Exact Sciences to Present New Molecular Residual Disease and Multi-Cancer Early Detection Data at AACR 20262026-03-04T14:00:00Z
BusinessWire
Exact Sciences Named Gallup Exceptional Workplace Award Winner for Third Consecutive Year2026-03-03T15:00:00Z
BusinessWire
Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration2026-02-20T21:05:00Z
BusinessWire
Exact Sciences Stockholders Approve Acquisition by Abbott2026-02-13T21:05:00Z
BusinessWire
Exact Sciences Announces Record Fourth Quarter and Full Year 2025 Results2026-02-03T19:32:00Z
BusinessWire
Exact Sciences Applauds Passage of Legislation Establishing Medicare Coverage Pathway for Multi-Cancer Early Detection Tests2026-02-03T14:03:00Z
BusinessWire
Oncotype DX Breast Recurrence Score® Test Surpasses 2 Million Patients Worldwide2026-02-02T15:30:00-05:00
PR Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger--JHG, FOLD, RAPT, and EXAS2026-01-21T15:58:00-05:00
PR Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, DBRG, FFIC, and EXAS2026-01-20T13:49:03Z
Analyst Upgrades
Mizuho Downgrades Exact Sciences to Neutral, Raises Price Target to $1052026-01-16T14:02:00-05:00
PR Newswire
Exact Sciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Exact Sciences Corporation - EXAS2026-01-08T12:48:00-05:00
PR Newswire
Halper Sadeh LLC Encourages FRGE, EXAS, CIVI, KVUE Shareholders to Contact the Firm to Discuss Their Rights2026-01-06T11:00:00-05:00
PR Newswire
Halper Sadeh LLC Encourages EXAS, SOAR, BTBD Shareholders to Contact the Firm to Discuss Their Rights2026-01-05T17:58:34Z
Analyst Upgrades
Evercore ISI Group Downgrades Exact Sciences to In-Line, Maintains Price Target to $105